Drug discovery for hearing loss: Phenotypic screening of chemical compounds on primary cultures of the spiral ganglion.

Abstract excerpt

In the United States there are, at present, no drugs that are specifically FDA approved to treat hearing loss. Although several clinical trials are ongoing, including one testing D-methionine that is supported by the US Army, none of these trials directly address the effect of noise exposure on cochlear spiral ganglion neurons. We recently published the first report of a systematic chemical compound screen using...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Hearing
• Share to Hearing Loss, Noise-Induced